Back to People & Entities
Aspreva Pharmaceuticals
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Document Mentions (1)
Microsoft Word - PPM Draft 2014.04.08 CLEAN.docx
1 mentionHOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
Apr 21, 2014Source: House Oversight Committee
Ron was previously on the boards of Cerexa (NLV-I company acquired by Forest Laboratories), Stromedix, Inc. (NLV-I company acquired by Biogen Idec), Aspreva Pharmaceuticals (NASDAQ: ASPV, acquired by Galenica, Inc.), Phase Forward (NASDAQ: PFWD, acquired by Oracle), and Pathology Partners (acquired by Caris Group). Befor
Page: HOUSE_OVERSIGHT_024023 →Sponsored
Connected Entities
No connected entities